Background: Subcutaneous implantable cardioverter-defibrillators (S-ICD) are an alternative to transvenous ICDs for patients without a need for cardiac pacing. Obese patients have been proposed to be at higher risk for conversion failure with S-ICDs due to subcutaneous fat underneath the device. Optimal device positioning may promote equivalent outcomes between obese and non-obese patients by minimizing the effects of excess adipose tissue.

Methods: A retrospective analysis of patients undergoing defibrillation testing at the time of S-ICD implantation was performed. The primary endpoint was the rate of successful conversion of ventricular fibrillation (VF) at the time of implant. The secondary endpoint was shock impedance.

Results: A total of 184 patients were included in the study. The rate of successful conversion of VF was 90.3% for obese patients (n = 72) and 96.4% for non-obese patients (n = 112) (p = 0.086). Compared to non-obese patients, obese patients had a higher mean PRAETORIAN score (78.5 ± 58.1 vs. 48.8 ± 35.5, p < 0.001) and higher measured mean impedance (82.0 ohms ± 26.5 vs. 69.8 ohms ± 19.3, p < 0.001). Patients with a PRAETORIAN score < 90 all had successful defibrillation testing regardless of BMI.

Conclusions: In this study, a PRAETORIAN score < 90 was associated with a 100% success rate of defibrillation testing following S-ICD implantation regardless of patient body mass index (BMI). Thus, the impact of obesity on impedance and the risk of failed shocks may be minimized with close attention to implantation technique to achieve a low PRAETORIAN score.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10840-022-01462-zDOI Listing

Publication Analysis

Top Keywords

non-obese patients
16
obese patients
12
patients
10
subcutaneous implantable
8
obese non-obese
8
rate successful
8
successful conversion
8
obese
5
implantable cardioverter-defibrillator
4
cardioverter-defibrillator implantation
4

Similar Publications

Obesity is associated with changes in the gut microbiota, as well as with increased permeability of the intestinal wall. In 130 non-obese volunteers, 57 patients with metabolically healthy obesity (MHO), and 76 patients with metabolically unhealthy obesity (MUHO), bacterial DNA was isolated from stool samples, and the 16S rRNA gene was sequenced. The metabolic profile of the microbiota predicted by PICRUSt2 (https://huttenhower.

View Article and Find Full Text PDF

Heamodialysis Arteriovenous Graft and the effect of obesity on patency. A Retrospective study.

Ann Vasc Surg

December 2024

Sheffield Kidney Institute, Northern General Hospital, Herries Road, Sheffield, United Kingdom, S5 7AU.

Obesity is growing in Haemodialysis population. Few scholars report variable effect of increased Body Mass Index (BMI) on native fistula. Reports on obesity effect on Arteriovenous Graft (AVG) patency are lacking.

View Article and Find Full Text PDF

Background: The aim of this study is to assess the impact of obesity on the perioperative outcomes in robotic pancreaticoduodenectomy (RPD), rarely documented.

Methods: A total of 886 patients undergoing RPD or open pancreaticoduodenectomy (OPD) were enroled. These patients were categorised into the obese RPD, non-obese RPD and obese OPD groups.

View Article and Find Full Text PDF

Identification of genetic loci enriched in obese or lean T2D cases in the Korean population.

Genes Genomics

December 2024

Department of Biomedical Science, Hallym University, Chuncheon, Gangwon State, 24252, Republic of Korea.

Background: Obesity causes many complex diseases including type 2 diabetes (T2D). Obesity increases the risk of T2D in Europeans, but there are many non-obese (lean) T2D patients in East Asia.

Objective: To discover genetic factors enriched in obese or lean T2D patients, we conducted a genome-wide association (GWA) analysis for T2D stratified by BMI in the Korean population.

View Article and Find Full Text PDF

Obesity: Friend or Foe in Sjögren's Syndrome Patients?

Diagnostics (Basel)

December 2024

Division of Clinical Immunology, Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

Background/objectives: In Sjögren's syndrome, exocrine glands are destructed in an autoimmune-mediated process. Obesity is known to influence a wide range of diseases. This study aimed to examine whether obesity has an impact on the disease course of our patients with Sjögren's syndrome.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!